Radiomics is an emerging translational field of medicine based on the extraction of high-dimensional data from radiological images, with the purpose to reach reliable models to be applied into clinical practice for the purposes of diagnosis, prognosis and evaluation of disease response to treatment. We aim to provide the basic information on radiomics to radiologists and clinicians who are focused on breast cancer care, encouraging cooperation with scientists to mine data for a better application in clinical practice. We investigate the workflow and clinical application of radiomics in breast cancer care, as well as the outlook and challenges based on recent studies. Currently, radiomics has the potential ability to distinguish between benign and malignant breast lesions, to predict breast cancer’s molecular subtypes, the response to neoadjuvant chemotherapy and the lymph node metastases. Even though radiomics has been used in tumor diagnosis and prognosis, it is still in the research phase and some challenges need to be faced to obtain a clinical translation. In this review, we discuss the current limitations and promises of radiomics for improvement in further research.

Recent radiomics advancements in breast cancer: Lessons and pitfalls for the next future / F. Pesapane, A. Rotili, G.M. Agazzi, F. Botta, S. Raimondi, S. Penco, V. Dominelli, M. Cremonesi, B.A. Jereczek-Fossa, G. Carrafiello, E. Cassano. - In: CURRENT ONCOLOGY. - ISSN 1718-7729. - 28:4(2021 Aug), pp. 2351-2372. [10.3390/curroncol28040217]

Recent radiomics advancements in breast cancer: Lessons and pitfalls for the next future

F. Pesapane
Primo
;
F. Botta;S. Raimondi;S. Penco;B.A. Jereczek-Fossa
Penultimo
;
G. Carrafiello
Ultimo
;
2021-08

Abstract

Radiomics is an emerging translational field of medicine based on the extraction of high-dimensional data from radiological images, with the purpose to reach reliable models to be applied into clinical practice for the purposes of diagnosis, prognosis and evaluation of disease response to treatment. We aim to provide the basic information on radiomics to radiologists and clinicians who are focused on breast cancer care, encouraging cooperation with scientists to mine data for a better application in clinical practice. We investigate the workflow and clinical application of radiomics in breast cancer care, as well as the outlook and challenges based on recent studies. Currently, radiomics has the potential ability to distinguish between benign and malignant breast lesions, to predict breast cancer’s molecular subtypes, the response to neoadjuvant chemotherapy and the lymph node metastases. Even though radiomics has been used in tumor diagnosis and prognosis, it is still in the research phase and some challenges need to be faced to obtain a clinical translation. In this review, we discuss the current limitations and promises of radiomics for improvement in further research.
Artificial intelligence; Breast cancer; Medical physics; Oncology; Radiology; Radiomics; Radiotherapy; Female; Humans; Lymphatic Metastasis; Neoadjuvant Therapy; Prognosis; Breast Neoplasms; Radiology
Settore MED/36 - Diagnostica per Immagini e Radioterapia
Article (author)
File in questo prodotto:
File Dimensione Formato  
curroncol-28-00217-v2.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 607.59 kB
Formato Adobe PDF
607.59 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/906810
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 5
social impact